146 related articles for article (PubMed ID: 25535009)
21. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
[TBL] [Abstract][Full Text] [Related]
22. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
[TBL] [Abstract][Full Text] [Related]
23. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
[TBL] [Abstract][Full Text] [Related]
24. DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder.
Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Jun TY; Serretti A
J Int Med Res; 2012; 40(1):258-65. PubMed ID: 22429365
[TBL] [Abstract][Full Text] [Related]
25. The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.
Calabrò M; Fabbri C; Crisafulli C; Albani D; Forloni G; Kasper S; Sidoti A; Velardi E; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Hum Psychopharmacol; 2018 Nov; 33(6):e2682. PubMed ID: 30426571
[No Abstract] [Full Text] [Related]
26. Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms.
Halmai Z; Dome P; Vereczkei A; Abdul-Rahman O; Szekely A; Gonda X; Faludi G; Sasvari-Szekely M; Nemoda Z
J Affect Disord; 2013 Aug; 150(1):104-9. PubMed ID: 23602648
[TBL] [Abstract][Full Text] [Related]
27. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
[TBL] [Abstract][Full Text] [Related]
28. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
29. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
[TBL] [Abstract][Full Text] [Related]
30. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Wilkosc M; Skibinska M; Hauser J
J Affect Disord; 2011 Nov; 134(1-3):138-44. PubMed ID: 21764460
[TBL] [Abstract][Full Text] [Related]
32. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
[TBL] [Abstract][Full Text] [Related]
33. The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases.
Schmidt FM; Kirkby KC; Himmerich H
Psychiatr Danub; 2014 Sep; 26(3):288-90. PubMed ID: 25191779
[No Abstract] [Full Text] [Related]
34. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
[TBL] [Abstract][Full Text] [Related]
35. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
[TBL] [Abstract][Full Text] [Related]
36. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response.
Wong ML; Dong C; Maestre-Mesa J; Licinio J
Mol Psychiatry; 2008 Aug; 13(8):800-12. PubMed ID: 18504423
[TBL] [Abstract][Full Text] [Related]
38. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
39. Genetic studies of drug response and side effects in the STAR*D study, part 1.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
[No Abstract] [Full Text] [Related]
40. A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants.
Kanders SH; Pisanu C; Bandstein M; Jonsson J; Castelao E; Pistis G; Gholam-Rezaee M; Eap CB; Preisig M; Schiöth HB; Mwinyi J
Drug Dev Res; 2020 Feb; 81(1):102-113. PubMed ID: 31617956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
